Document is current

Article History

Received: 14 September 2024

Accepted: 19 December 2024

First Online: 31 December 2024

Declarations

:

: The study protocol was registered and confirmed in the Iranian Registry of Clinical Trials under the number (IRCT20220702055335N1). The present study has been approved by the Ethics Committee of Tabriz University of Medical Sciences with the approval number (IR.TBZMED.REC.1401.233). Written informed consent was obtained from the participants, granting them the right to participate or withdraw at any research stage. The research groups were assured of the confidentiality of their information. Integrity and honesty were maintained during data collection, review of available sources, etc. Upon request, research results will be made available to health centers. At the beginning of the participant's entry into the study, the researcher's contact number was provided so that they could receive necessary guidance in case of any problems or questions.

: Not applicable.

: The authors declare no competing interests.